MYD88 and neoplasm: While hepatocyte-specific deletion of MyD88/NEMO promotes the tumor progression in mice, this development was ablated in global Myd88/hepatocyte-specific knockouts of NEMO providing further evidence that inflammatory signaling through TLR in non- parenchymal cells of the liver is a driver of disease progression and might be a relevant target for disease treatment or prevention (152).